
Crude oil slid as traders priced in a potential US-Iran deal that could reopen Hormuz flows. The market now tests the $84.20–$85.20 support zone, with resistance at $96.90. A breakdown below support would signal further downside risk.
Crude oil slid sharply as traders began pricing the possibility of a US-Iran peace deal that would reopen oil flows through the Strait of Hormuz. The move pushed prices into a well-defined support zone between $84.20 and $85.20, a level that had previously acted as a floor during the March pullback. The catalyst is straightforward: any diplomatic breakthrough that eases sanctions on Iranian exports would add meaningful barrels to a market already adjusting to slower demand growth. The immediate reaction sent oil below its 20-day moving average, but the real test is whether the support zone can hold on a closing basis.
The Strait of Hormuz remains the single most important chokepoint for global oil supply, with roughly 20% of the world's crude passing through it daily. A peace deal would not only lift sanctions on Iranian crude but also reduce the geopolitical risk premium that has kept a floor under prices for months. The market's initial drop reflects a rapid repricing of that premium, but the full impact depends on the timeline of any agreement and the pace at which Iran can ramp up exports. Previous attempts at a deal have stalled, so the current sell-off may be front-running an outcome that is far from certain. For traders, the key is to separate the headline reaction from the actual supply change. Even if a framework is announced, it could take months before additional barrels hit the market, leaving room for a sharp reversal if talks collapse.
A simple chart read would treat the $84.20–$85.20 area as an automatic buy zone, but first touches of support rarely offer the best risk/reward. The better approach is to wait for confirmation that buyers are stepping in. That means watching for a daily close above the zone, ideally with a bullish engulfing candle or a sharp rejection wick on high volume. Without that, the risk is that the support merely pauses the decline before a deeper flush toward the 200-day moving average near $79.50. The RSI on the daily chart has not yet reached oversold territory, suggesting there is still room for further downside if the news flow worsens. A breakdown below $84.20 on a closing basis would invalidate the support zone and open a path to the next structural level around $80.00. Until then, the zone is a battleground, not a signal.
The upper boundary of the current trading range sits at $96.90, a level that capped the April rally and aligns with the 50% Fibonacci retracement of the 2022–2023 decline. If support holds, the market could carve out a broad $84.20–$96.90 range, offering swing-trade opportunities on both sides. However, the catalyst risk is asymmetric: a failed deal would likely send oil back toward $96.90 quickly, while a successful deal could break the range to the downside. That skews the risk/reward for long positions at support, making it essential to use tight stops and to scale into any bounce only after confirmation. The weekly chart shows that the $96.90 level also coincides with the upper Bollinger Band, adding to its technical significance. A move above that level would signal that the market has fully discounted the Iran risk and is focusing on other supply constraints.
The next concrete decision point is the scheduled round of talks in Vienna later this week. Any sign of progress or breakdown will dictate whether the support zone holds or fails. Until then, oil is likely to chop within the $84.20–$85.20 band, with intraday spikes driven by headlines. Traders should monitor the Oil at 50-Day EMA on Iran Peace Hopes: What It Means for Dollar, CAD for the broader FX implications, as a sustained drop in crude would weigh on the Canadian dollar and other petrocurrencies. The setup is clear: wait for a confirmed reaction at support before committing capital, and keep position sizes small ahead of the binary event risk.
AI-drafted from named sources and checked against AlphaScala publishing rules before release. Direct quotes must match source text, low-information tables are removed, and thinner or higher-risk stories can be held for manual review.